InvestorsHub Logo

teq0904

10/20/19 12:39 PM

#129 RE: onin2downin2 #128

It is a private company, called CNA. All tests have been on Caucasians but a multi race result will be out in Dec, which if the results are as good as the others, will be used on their FDA application.
Thus, a year later T2 would face competition from a more useful test, which would be especially troublesome if CNA succeeds with the additional bacterial and fungal as well as gram + and - differentiators before symptoms show up. Can T2 do either of these additional 2?
Some patients could be cured before symptoms show up.
https://cnadiagnostics.com/cna-rapid-sepsis-dx/